Earnings Feed
Start Free
Home/Insiders/Runge Jeffrey W.
RJ
SEC Insider//CIK 0001479091

Runge Jeffrey W.

CIK 00014790913 companiesANNAPOLIS, MD
SEC Profile

Transactions

30

Companies

3

Filings

12

CIK

0001479091

Recent Transactions

30 trades
  • Award
    Aditxt, Inc.$ADTX

    Options (right to buy)

    2023-11-08+470→ 470 total
  • Award
    Aditxt, Inc.$ADTX

    Restricted Stock Units

    2021-09-29+11,500→ 11,500 total
  • Purchase
    Aditxt, Inc.$ADTX

    Common Stock

    2021-06-01$2.94/sh+700→ 3,200 total
  • Purchase
    Aditxt, Inc.$ADTX

    Common Stock

    2021-06-01$2.94/sh+3,000→ 12,500 total
  • Purchase
    Aditxt, Inc.$ADTX

    Common Stock

    2021-06-01$2.94/sh+700→ 3,900 total
  • Purchase
    Aditxt, Inc.$ADTX

    Common Stock

    2021-06-01$2.93/sh+2,000→ 9,500 total
  • Purchase
    Aditxt, Inc.$ADTX

    Common Stock

    2021-06-01$2.93/sh+1,600→ 5,500 total
  • Purchase
    Aditxt, Inc.$ADTX

    Common Stock

    2021-06-01$2.93/sh+2,000→ 7,500 total
  • Disposition to Issuer
    Aditxt, Inc.$ADTX

    Stock Option (Right to Buy)

    2020-10-13−10,000→ 10,000 total
  • Award
    Aditxt, Inc.$ADTX

    Stock Option (Right to Buy)

    2020-10-13+10,000→ 10,000 total
  • Exercise/Conversion
    Altimmune, Inc.$ALT

    Common Stock, par value $0.0001 per share

    2017-01-20$3.11/sh+20,000→ 197,700 total
  • Exercise/Conversion
    Altimmune, Inc.$ALT

    Stock Option (right to buy)

    2017-01-20−20,000→ 0 total
  • Exercise/Conversion
    Altimmune, Inc.$ALT

    Common Stock, par value $0.0001 per share

    2016-11-28$2.20/sh+20,000→ 177,700 total
  • Exercise/Conversion
    Altimmune, Inc.$ALT

    Stock Option (right to buy)

    2016-11-28−20,000→ 0 total
  • Exercise/Conversion
    Altimmune, Inc.$ALT

    Employee Stock Option (right to buy)

    2016-09-15−20,000→ 0 total
  • Exercise/Conversion
    Altimmune, Inc.$ALT

    Common Stock, par value $0.0001 per share

    2016-09-15$1.35/sh+20,000→ 57,700 total
  • Award
    Altimmune, Inc.$ALT

    Stock option (right to buy)

    2016-06-01$2.20/sh+20,000→ 20,000 total
  • Award
    Altimmune, Inc.$ALT

    Stock option (right to buy)

    2015-08-02+20,000→ 20,000 total
  • Award
    Altimmune, Inc.$ALT

    Stock option (right to buy)

    2013-06-11+20,000→ 20,000 total
  • Disposition to Issuer
    Conmed Healthcare Management, Inc.

    Employee Stock Option (right to buy)

    2012-08-29$0.68/sh−40,000→ 0 total
  • Disposition to Issuer
    Conmed Healthcare Management, Inc.

    Common Stock

    2012-08-28$3.95/sh−10,000→ 0 total
  • Award
    Altimmune, Inc.$ALT

    Stock option (right to buy)

    2012-06-22+20,000→ 20,000 total
  • Exercise/Conversion
    Conmed Healthcare Management, Inc.

    Common Stock

    2012-05-24+10,000→ 10,000 total
  • Award
    Conmed Healthcare Management, Inc.

    Restricted Stock Units

    2012-02-21+10,000→ 10,000 total
  • Purchase
    Altimmune, Inc.$ALT

    Common stock, $0.0001 par value per share

    2011-12-12$1.30/sh+20,000→ 20,000 total
  • Award
    Altimmune, Inc.$ALT

    Stock option (right to buy)

    2011-06-23+20,000→ 20,000 total
  • Purchase
    Altimmune, Inc.$ALT

    Common stock, $0.0001 par value per share

    2011-06-17$2.69/sh+17,850→ 17,850 total
  • Award
    Conmed Healthcare Management, Inc.

    Stock Option (right to buy)

    2011-01-14+40,000→ 40,000 total
  • Award
    Altimmune, Inc.$ALT

    Stock option (right to buy)

    2010-06-23+20,000→ 20,000 total
  • Award
    Altimmune, Inc.$ALT

    Stock Option (right to buy)

    2009-12-17+20,000→ 20,000 total

Companies

3

Recent Filings

12

Address

C/O PHARMATHENE, INC. ONE PARK PLACE, SUITE 450

ANNAPOLIS, MD, 21401

View on SEC.gov